87441-2  Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM panel: -: Pt: XXX: -: IA  

PANEL HIERARCHY  (view this panel in the LForms viewer)

  LOINC#   LOINC Name R/O/C  Cardinality  Ex. UCUM Units 
  87441-2   Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM panel: -: Pt: XXX: -: IA    
       87440-4   Dengue virus 1+​2+​3+​4 IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayDengue virus 1+​2+​3+​4 IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayDengue virus 1+​2+​3+​4 Ab.IgA+​IgG+​IgM: Imp: Pt: XXX: Ord: IA    
       87439-6   Zika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayZika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayZika virus Ab.IgA+​IgG+​IgM: Imp: Pt: XXX: Ord: IA    
       87438-8   Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM: Imp: Pt: XXX: Nom: IA    
 

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel  Pt  XXX  IA
  Long Common Name:  Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel - Unspecified specimen by Immunoassay
  Shortname:  DENV1-4 + Zika IgA+IgG+IgM Pnl XXX IA
  DisplayName:  DENV 1+2+3+4 and Zika virus IgA+IgG+IgM panel IA (Unsp spec)

TERM DEFINITION/DESCRIPTION(S)
  This panel contains individual qualitative results for Zika and Dengue virus antibodies (IgG,IgM,IgA) as well as an overall interpretation. The primary specimen used for testing is serum but other specimens, such as CSF, may be analyzed. This term was created for, but not limited in use to, a Flavivirus multiplex microsphere immunofluorescence assay (MIA) performed by the New York State Department of Health. The lab uses this test in conjunction with the Zika IgM ELISA for Zika IgM antibodies, the West Nile Envelope MIA test, which tests for antibodies to West Nile, Powassan, and reflex Plaque Reduction Neutralization testing on paired sera to provide serological evidence of infection with a Flavivirus.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.MICRO/Lab
  Panel Type: Panel
  First Released in Version: 2.63
  Last Updated in Version: 2.63
  Order vs. Obs.: Order
  Status: Active

MEMBER OF THESE EQUIVALENCE GROUPS
  LG32760-7  Dengue virus

PARTS

Part Type    Part No.  Part Name   
Component   LP262577-2  Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel   [Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel] 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7747-1 
Method   LP217197-5  IA   [Immunoassay] 
Fragments for synonyms   LP20740-4 
Fragments for synonyms   LP21059-8  Panel 
Fragments for synonyms   LP21265-1 
Fragments for synonyms   LP21267-7 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  登革热病毒 1+​2+​3+​4 型与寨卡病毒抗体.IgA+​IgG+​IgM 组套:-:时间点:XXX:-:免疫测定法登革热病毒 1+​2+​3+​4 型与寨卡病毒抗体.IgA+​IgG+​IgM 组套:-:时间点:XXX:-:免疫测定法
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Dengue virus 1+​2+​3+​4 et Zika virus Ac IgA+​IgG+​IgM panel:-:Ponctuel:Milieux divers:-:ImmunoanalyseDengue virus 1+​2+​3+​4 et Zika virus Ac IgA+​IgG+​IgM panel:-:Ponctuel:Milieux divers:-:ImmunoanalyseDengue virus 1+​2+​3+​4 et Zika virus Ac IgA+​IgG+​IgM panel [-] Milieux divers ; - ; Immunoanalyse
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  panel de anticuerpos Ig G+​Ig A+​Ig M para virus Dengue 1+​2+​3+​4 y virus Zika:Propiedades mixtas (sólo paneles):Punto temporal:XXX:-:IApanel de anticuerpos Ig G+​Ig A+​Ig M para virus Dengue 1+​2+​3+​4 y virus Zika:Propiedades mixtas (sólo paneles):Punto temporal:XXX:-:IA

RELATED NAMES
  Breakbone fever i Other
  Dengue type I IAA Pan
  Dengue type I+II+III+IV II PANEL.MICROBIOLOGY
  Denv III Panl
  DENV 1+2+3+4 Immune globulin A Pnl
  DENV1 Immune globulin G Point in time
  DENV1+2+3+4 Immune globulin M Random
  DENV1-4 + Zika Immunoglobulin A SUDS
  DENV1-4 + Zika IgA+IgG+IgM Pnl Immunoglobulin G To be specified in another part of the message
  EIA Immunoglobulin M Unspecified
  ELFA MEIA ZIKV
  ELISA Microbiology  
  Enzyme immunoassay Misc  
  Flavivirus Miscellaneous  

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 3:32:24 PM
  Long Common Name: Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel - Unspecified specimen by Immunoassay
  Shortname: DENV1-4 + Zika IgA+IgG+IgM Pnl XXX IA
  Fully Specified Name: Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel: -: Pt: XXX: -: IA
     
  Component Word Count: 13
  ID: 93739
  # of Panel Elements: 4
  Status (Raw): ACTIVE



Selected information about each LOINC that is part of this panel



87440-4   Dengue virus 1+​2+​3+​4 IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayDengue virus 1+​2+​3+​4 IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayDengue virus 1+​2+​3+​4 Ab.IgA+​IgG+​IgM: Imp: Pt: XXX: Ord: IA  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Dengue virus 1+2+3+4 Ab.IgA+IgG+IgM  Imp  Pt  XXX  Ord  IA
  Long Common Name:  Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay
  Shortname:  DENV1+2+3+4 IgA+IgG+IgM XXX IA-Imp
  DisplayName:  DENV 1+2+3+4 IgA+IgG+IgM IA Ql (Unsp spec) [Interp]

TERM DEFINITION/DESCRIPTION(S)
  Overall qualitative results for Dengue virus antibody (IgG,IgM,IgA) testing based on an algorithm that considers individual quantitative results for antibodies to various Zika virus and Dengue virus target antigens. This term was created for, but not limited in use to, a Flavivirus multiplex microsphere immunofluorescence assay (MIA) performed by the New York State Department of Health.
 
 

PART DEFINITION/DESCRIPTION(S)
  Part: Dengue virus 1+2+3+4
  Dengue is caused by any one of four distinct but closely related dengue virus (DENV) serotypes (DENV-1, -2, -3, and -4), which are single-stranded RNA viruses in family Flaviviridae, genus Flavivirus. This family includes other important vector-borne viruses (e.g., West Nile virus, Yellow Fever virus, Japanese Encephalitis virus, St. Louis Encephalitis virus, etc.). Dengue viruses are arboviruses (arthropod-borne virus) transmitted primarily to humans through an infected Aedes species mosquito bite. Transmission may also occur through transfusion of infected blood or transplantation of infected organs or tissues or after occupational exposure in healthcare settings. All four dengue serotypes can produce the full spectrum of illness and severity. The spectrum of illness can range from a mild febrile syndrome to classic dengue fever (DF), to the severe forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
 
 

BASIC ATTRIBUTES
  Class/Type: MICRO/Lab
  First Released in Version: 2.63
  Last Updated in Version: 2.63
  Order vs. Obs.: Both
  Status: Active

EXAMPLE ANSWER LIST    (LL2017-3)  
 
Source: Siemens
  SEQ#        Answer        Answer ID    
  1       Indeterminate
http://snomed.info/sct ©: 82334004 Indeterminate (qualifier value)    
  LA11884-6  
  2       Reactive
http://snomed.info/sct ©: 11214006 Reactive (qualifier value)    
  LA15255-5  
  3       Nonreactive
http://snomed.info/sct ©: 131194007 Non-reactive (qualifier value)    
  LA15256-3  

MEMBER OF THESE PANELS
  87441-2   Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM panel: -: Pt: XXX: -: IA

MEMBER OF THESE EQUIVALENCE GROUPS
  LG32760-7  Dengue virus

PARTS

Part Type    Part No.  Part Name   
Component   LP17691-4  Dengue virus 1+2+3+4 
     Suffix   LP32405-0  Ab.IgA+IgG+IgM   [IgA+IgG+IgM] 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7751-3  Ord 
Method   LP217197-5  IA   [Immunoassay] 
Fragments for synonyms   LP20740-4 
Fragments for synonyms   LP21265-1 
Fragments for synonyms   LP21267-7 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  登革热病毒 1+​2+​3+​4 型 抗体.IgA+​IgG+​IgM:印象:时间点:XXX:序数型:免疫测定法登革热病毒 1+​2+​3+​4 型 抗体.IgA+​IgG+​IgM:印象:时间点:XXX:序数型:免疫测定法
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  Denguevirus 1+​2+​3+​4 As.IgA +​ IgG +​ IgM:interpretatie:moment:XXX:ordinaal:immunoassayDenguevirus 1+​2+​3+​4 As.IgA +​ IgG +​ IgM:interpretatie:moment:XXX:ordinaal:immunoassay
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Virus de la dengue 1+​2+​3+​4 Anticorps. IgA+​IgG+​IgM:Impression/​interprétation d'étude:Temps ponctuel:XXX:Ordinal:IAVirus de la dengue 1+​2+​3+​4 Anticorps. IgA+​IgG+​IgM:Impression/​interprétation d'étude:Temps ponctuel:XXX:Ordinal:IA
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Virus de la dengue 1+​2+​3+​4 , IgA+​IgG+​IgM:Impression/​interprétation d'étude:Temps ponctuel:XXX:Ordinal:IAVirus de la dengue 1+​2+​3+​4 , IgA+​IgG+​IgM:Impression/​interprétation d'étude:Temps ponctuel:XXX:Ordinal:IA
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Dengue virus 1+​2+​3+​4 Ac IgA+​IgG+​IgM:Interprétation:Ponctuel:Milieux divers:Qualitatif:ImmunoanalyseDengue virus 1+​2+​3+​4 Ac IgA+​IgG+​IgM:Interprétation:Ponctuel:Milieux divers:Qualitatif:ImmunoanalyseDengue virus 1+​2+​3+​4 Ac IgA+​IgG+​IgM [Interprétation] Milieux divers ; Qualitatif ; Immunoanalyse
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Dengue virus 1+​2+​3+​4 , Ab.IgA+​IgG+​IgM:Imp:Pt:XXX:Ord:IADengue virus 1+​2+​3+​4 , Ab.IgA+​IgG+​IgM:Imp:Pt:XXX:Ord:IA
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Денге вирус 1+​2+​3+​4 Ат.IgA+​IgG+​IgM:Впчт:ТчкВрм:XXX:Пор:IAДенге вирус 1+​2+​3+​4 Ат.IgA+​IgG+​IgM:Впчт:ТчкВрм:XXX:Пор:IA
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Virus Dengue 1+​2+​3+​4 IgA+​IgG+​IgM:Impresión/​interpretación del estudio:Punto temporal:XXX:Ord:IAVirus Dengue 1+​2+​3+​4 IgA+​IgG+​IgM:Impresión/​interpretación del estudio:Punto temporal:XXX:Ord:IA
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Dengue virus 1+​2+​3+​4 Ab.IgA+​IgG+​IgM:İzlnm:Zmlı:XXX:Srl:İADengue virus 1+​2+​3+​4 Ab.IgA+​IgG+​IgM:İzlnm:Zmlı:XXX:Srl:İA

RELATED NAMES
  ABS ELISA Interpretation
  Aby Enzyme immunoassay MEIA
  Antby Flavivirus Microbiology
  Anti i Misc
  Antibodies IAA Miscellaneous
  Antibody II Ordinal
  Autoantibodies III Other
  Autoantibody Immune globulin A Point in time
  Breakbone fever Immune globulin G QL
  Dengue type I Immune globulin M Qual
  Dengue type I+II+III+IV Immunoglobulin A Qualitative
  Denv Immunoglobulin G Random
  DENV 1+2+3+4 Immunoglobulin M Screen
  DENV1 Impression SUDS
  DENV1+2+3+4 Impression/interpretation of study To be specified in another part of the message
  EIA Impressions Unspecified
  ELFA Interp  

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 3:32:24 PM
  Long Common Name: Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay
  Shortname: DENV1+2+3+4 IgA+IgG+IgM XXX IA-Imp
  Fully Specified Name: Dengue virus 1+2+3+4 Ab.IgA+IgG+IgM: Imp: Pt: XXX: Ord: IA
     
  Component Word Count: 10
  ID: 93738
  Status (Raw): ACTIVE


87439-6   Zika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayZika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen Qualitative by ImmunoassayZika virus Ab.IgA+​IgG+​IgM: Imp: Pt: XXX: Ord: IA  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Zika virus Ab.IgA+IgG+IgM  Imp  Pt  XXX  Ord  IA
  Long Common Name:  Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay
  Shortname:  ZIKV IgA+IgG+IgM XXX IA-Imp
  DisplayName:  ZIKV IgA+IgG+IgM IA Ql (Unsp spec) [Interp]

TERM DEFINITION/DESCRIPTION(S)
  Overall qualitative result for Zika virus antibody (IgG,IgM,IgA) based on an algorithm that considers individual quantitative results for antibodies to various target antigens. This term was created for, but not limited in use to, a Flavivirus multiplex microsphere immunofluorescence assay (MIA) performed by the New York State Department of Health.
 
 

PART DEFINITION/DESCRIPTION(S)
  Part: Zika virus
  Zika virus (ZIKV) is a flavivirus transmitted primarily by the Aedes mosquito which was first identified in a sentinel monkey in the Zika forest in Uganda in 1947. Since 2014 it has spread explosively in the Americas where it has infected hundreds of thousands of people. About 80% of those infected are asymptomatic. Common symptoms include fever, headache, rash, arthralgia and conjunctivitis. Since the end of 2015, there has been an increase in ZIKV-associated cases of Guillain-Barre syndrome and a tremendous increase in cases of microcephaly in fetuses and newborns in Brazil, raising worldwide public health concern. Recent predictions are that the mosquito species A. Albopictus, which can hibernate and survive cool temperatures, will carry ZIKV to more temperate areas of North America, Australia and Southern Europe. It is still not clear whether ZIKV in humans increases viral titers enough to trigger a new cycle when an infected person is bitten by a naïve mosquito. Direct human-to-human transmission has been documented to occur perinatally, sexually (primarily through semen), through breastfeeding, blood transfusion and through occupational transmission in the laboratory setting. There are currently no specific anti-viral agents, vaccination or medical prophylaxis available. [PMID: 27148186]
 
 

BASIC ATTRIBUTES
  Class/Type: MICRO/Lab
  First Released in Version: 2.63
  Last Updated in Version: 2.63
  Order vs. Obs.: Both
  Status: Active

EXAMPLE ANSWER LIST    (LL2017-3)  
 
Source: Siemens
  SEQ#        Answer        Answer ID    
  1       Indeterminate
http://snomed.info/sct ©: 82334004 Indeterminate (qualifier value)    
  LA11884-6  
  2       Reactive
http://snomed.info/sct ©: 11214006 Reactive (qualifier value)    
  LA15255-5  
  3       Nonreactive
http://snomed.info/sct ©: 131194007 Non-reactive (qualifier value)    
  LA15256-3  

MEMBER OF THESE PANELS
  87441-2   Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM panel: -: Pt: XXX: -: IA

MEMBER OF THESE EQUIVALENCE GROUPS
  LG32774-8  Zika virus

PARTS

Part Type    Part No.  Part Name   
Component   LP200137-0  Zika virus 
     Suffix   LP32405-0  Ab.IgA+IgG+IgM   [IgA+IgG+IgM] 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7751-3  Ord 
Method   LP217197-5  IA   [Immunoassay] 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  寨卡病毒 抗体.IgA+​IgG+​IgM:印象:时间点:XXX:序数型:免疫测定法寨卡病毒 抗体.IgA+​IgG+​IgM:印象:时间点:XXX:序数型:免疫测定法
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  zikavirus As.IgA +​ IgG +​ IgM:interpretatie:moment:XXX:ordinaal:immunoassayzikavirus As.IgA +​ IgG +​ IgM:interpretatie:moment:XXX:ordinaal:immunoassay
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Zika virus Ac IgA+​IgG+​IgM:Interprétation:Ponctuel:Milieux divers:Qualitatif:ImmunoanalyseZika virus Ac IgA+​IgG+​IgM:Interprétation:Ponctuel:Milieux divers:Qualitatif:ImmunoanalyseZika virus Ac IgA+​IgG+​IgM [Interprétation] Milieux divers ; Qualitatif ; Immunoanalyse
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Zika virus , Ab.IgA+​IgG+​IgM:Imp:Pt:XXX:Ord:IAZika virus , Ab.IgA+​IgG+​IgM:Imp:Pt:XXX:Ord:IA
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Virus Zika IgA+​IgG+​IgM:Impresión/​interpretación del estudio:Punto temporal:XXX:Ord:IAVirus Zika IgA+​IgG+​IgM:Impresión/​interpretación del estudio:Punto temporal:XXX:Ord:IA
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Zika virüs Ab.IgA+​IgG+​IgM:İzlnm:Zmlı:XXX:Srl:İAZika virüs Ab.IgA+​IgG+​IgM:İzlnm:Zmlı:XXX:Srl:İA

RELATED NAMES
  ABS Immune globulin G Ordinal
  Aby Immune globulin M Other
  Antby Immunoglobulin A Point in time
  Anti Immunoglobulin G QL
  Antibodies Immunoglobulin M Qual
  Antibody Impression Qualitative
  Autoantibodies Impression/interpretation of study Random
  Autoantibody Impressions Screen
  EIA Interp SUDS
  ELFA Interpretation To be specified in another part of the message
  ELISA MEIA Unspecified
  Enzyme immunoassay Microbiology ZIKV
  IAA Misc  
  Immune globulin A Miscellaneous  

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 3:32:24 PM
  Long Common Name: Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay
  Shortname: ZIKV IgA+IgG+IgM XXX IA-Imp
  Fully Specified Name: Zika virus Ab.IgA+IgG+IgM: Imp: Pt: XXX: Ord: IA
     
  Component Word Count: 6
  ID: 93737
  Status (Raw): ACTIVE


87438-8   Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM Ab [Interpretation] in Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM: Imp: Pt: XXX: Nom: IA  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM  Imp  Pt  XXX  Nom  IA
  Long Common Name:  Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen by Immunoassay
  Shortname:  DENV1-4 + Zika IgA+IgG+IgM XXX IA-Imp
  DisplayName:  DENV 1+2+3+4 and Zika virus IgA+IgG+IgM IA (Unsp spec) [Interp]

TERM DEFINITION/DESCRIPTION(S)
  The overall interpretation for Zika virus and dengue virus antibody (IgG,IgM,IgA) testing based on the individual results for Zika and Dengue virus antibodies. This term was created for, but not limited in use to, a Flavivirus multiplex microsphere immunofluorescence assay (MIA) performed by the New York State Department of Health.
 
 

BASIC ATTRIBUTES
  Class/Type: MICRO/Lab
  First Released in Version: 2.63
  Last Updated in Version: 2.63
  Order vs. Obs.: Observation
  Status: Active

EXAMPLE ANSWER LIST    (LL4634-3)  
 
Source: New York State Health (Wadsworth Center)
  SEQ#        Answer        Answer ID    
  1       Results suggest the absence of Zika and dengue antibodies.       LA28039-8  
  2       Results suggest the presence of Zika and dengue antibodies.       LA28040-6  
  3       Results suggest the presence of dengue antibodies.       LA28041-4  
  4       Results suggest the presence of Zika antibodies.       LA28043-0  
  5       Results suggest the presence of Zika antibodies and indeterminate for dengue antibodies.       LA28042-2  
  6       Indeterminate results for the presence of Zika antibodies and nonreactive for dengue antibodies.       LA28044-8  
  7       Indeterminate results for the presence of Zika antibodies and reactive for dengue antibodies.       LA28045-5  
  8       Nonreactive results for the presence of Zika antibodies and indeterminate for dengue antibodies.       LA28046-3  
  9       Indeterminate results for the presence of both Zika and dengue antibodies.       LA28047-1  

MEMBER OF THESE PANELS
  87441-2   Dengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 and Zika virus IgA+​IgG+​IgM panel - Unspecified specimen by ImmunoassayDengue virus 1+​2+​3+​4 & Zika virus Ab.IgA+​IgG+​IgM panel: -: Pt: XXX: -: IA

MEMBER OF THESE EQUIVALENCE GROUPS
  LG32760-7  Dengue virus

PARTS

Part Type    Part No.  Part Name   
Component   LP262542-6  Dengue virus 1+2+3+4 & Zika virus   [Dengue virus 1+2+3+4 and Zika virus] 
Component   LP262576-4  Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM   [Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM] 
     Suffix   LP32405-0  Ab.IgA+IgG+IgM   [IgA+IgG+IgM] 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Method   LP217197-5  IA   [Immunoassay] 
Fragments for synonyms   LP21267-7 
Fragments for synonyms   LP20740-4 
Fragments for synonyms   LP21265-1 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  登革热病毒 1+​2+​3+​4 型与寨卡病毒 抗体.IgA+​IgG+​IgM:印象:时间点:XXX:名义型:免疫测定法登革热病毒 1+​2+​3+​4 型与寨卡病毒 抗体.IgA+​IgG+​IgM:印象:时间点:XXX:名义型:免疫测定法
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  Denguevirus 1+​2+​3+​4 & Zikavirus As.IgA +​ IgG +​ IgM:interpretatie:moment:XXX:nominaal:immunoassayDenguevirus 1+​2+​3+​4 & Zikavirus As.IgA +​ IgG +​ IgM:interpretatie:moment:XXX:nominaal:immunoassay
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Dengue virus 1+​2+​3+​4 et Zika virus Ac IgA+​IgG+​IgM:Interprétation:Ponctuel:Milieux divers:Résultat textuel:ImmunoanalyseDengue virus 1+​2+​3+​4 et Zika virus Ac IgA+​IgG+​IgM:Interprétation:Ponctuel:Milieux divers:Résultat textuel:ImmunoanalyseDengue virus 1+​2+​3+​4 et Zika virus Ac IgA+​IgG+​IgM [Interprétation] Milieux divers ; Résultat textuel ; Immunoanalyse
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Virus Dengue 1+​2+​3+​4 & virus Zika IgA+​IgG+​IgM:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:IAVirus Dengue 1+​2+​3+​4 & virus Zika IgA+​IgG+​IgM:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:IA

RELATED NAMES
  ABS ELFA Interp
  Aby ELISA Interpretation
  Antby Enzyme immunoassay MEIA
  Anti Flavivirus Microbiology
  Antibodies i Misc
  Antibody IAA Miscellaneous
  Autoantibodies II Nominal
  Autoantibody III Other
  Breakbone fever Immune globulin A Point in time
  Dengue type I Immune globulin G Random
  Dengue type I+II+III+IV Immune globulin M SUDS
  Denv Immunoglobulin A To be specified in another part of the message
  DENV 1+2+3+4 Immunoglobulin G Unspecified
  DENV1 Immunoglobulin M ZIKV
  DENV1+2+3+4 Impression  
  DENV1-4 + Zika Impression/interpretation of study  
  EIA Impressions  

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 3:32:25 PM
  Long Common Name: Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen by Immunoassay
  Shortname: DENV1-4 + Zika IgA+IgG+IgM XXX IA-Imp
  Fully Specified Name: Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM: Imp: Pt: XXX: Nom: IA
     
  Component Word Count: 12
  ID: 93736
  Status (Raw): ACTIVE

3rd PARTY COPYRIGHT
  Code System: http://snomed.info/sct
  This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. “SNOMED” and “SNOMED CT” are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org. This may incur a fee in SNOMED International non-Member countries.